Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 14-Dec-23 9:00 AM View:  | Hill Mathew C Chief Financial Officer | Bovie Medical Corp. (APYX) | 12-Dec-23 | Private Purchase | 2,500 | $2.19 | $5,475.00 | 100% 0 to 2.5K | |
| 15-Nov-23 4:12 PM View: | Goodwin Charles D. II Chief Executive Officer Director | Bovie Medical Corp. (APYX) | 14-Nov-23 | Private Purchase | 50,000 | $1.57 | $78,500.00 | 125% 40.0K to 90.0K | |
| 19-Jul-23 12:00 PM View: | Waldman Lawrence Director | Bovie Medical Corp. (APYX) | 12-Jul-23 | Option Exercise | 5,338 | $2.97 | $15,853.90 | 14% 37.56K to 42.9K | |
| 28-Jun-23 2:01 PM View: | Hornsby Todd Executive Vice President | Bovie Medical Corp. (APYX) | 26-Jun-23 | Planned Option Sale | 15,000 | $7.56 | $113,400.00 | (100%) 15.04K to 40 | |
| 28-Jun-23 2:01 PM View: | Hornsby Todd Executive Vice President | Bovie Medical Corp. (APYX) | 26-Jun-23 | Option Exercise | 15,000 | $1.77 | $26,550.00 | 37500% 40 to 15.04K | |
| 09-Jun-23 12:06 PM View: | Geraghty Michael Director | Bovie Medical Corp. (APYX) | 06-Jun-23 | Option Exercise | 10,000 | $2.79 | $27,900.00 | 57% 17.5K to 27.5K | |
| 31-Aug-22 4:51 PM View: | Goodwin Charles D. II Chief Executive Officer Director | Bovie Medical Corp. (APYX) | 29-Aug-22 | Private Purchase | 11,750 | $5.96 | $70,067.50 | 42% 28.25K to 40.0K | |
| 11-Jul-22 4:54 PM View: | Waldman Lawrence Director | Bovie Medical Corp. (APYX) | 11-Jul-22 | Option Exercise | 24,000 | $2.54 | $60,960.00 | 177% 13.56K to 37.56K | |
| 12-Jul-22 11:56 AM View: | Citronowicz Moshe Sr. V.P. of Operations | Bovie Medical Corp. (APYX) | 11-Jul-22 | Option Exercise | 30,000 | $2.54 | $76,200.00 | 7% 426.5K to 456.5K | |
| 11-Jul-22 10:22 AM View: | Geraghty Michael Director | Bovie Medical Corp. (APYX) | 06-Jul-22 | Option Exercise | 4,000 | $2.54 | $10,160.00 | 30% 13.5K to 17.5K | |
| 11-Jul-22 3:54 PM View: | Makrides Andrew Director | Bovie Medical Corp. (APYX) | 05-Jul-22 | Payment of Exercise | 13,583 | $6.14 | $83,399.60 | (2%) 637.97K to 624.39K | |
| 11-Jul-22 3:54 PM View: | Makrides Andrew Director | Bovie Medical Corp. (APYX) | 05-Jul-22 | Option Exercise | 30,000 | $2.54 | $76,200.00 | 5% 607.97K to 637.97K | |
| 23-May-22 10:26 AM View: | Waldman Lawrence Director | Bovie Medical Corp. (APYX) | 19-May-22 | Option Exercise | 8,000 | $2.79 | $22,320.00 | 144% 5.56K to 13.56K | |
| 19-May-22 1:23 PM View: | Geraghty Michael Director | Bovie Medical Corp. (APYX) | 11-May-22 | Option Exercise | 6,000 | $2.79 | $16,740.00 | 80% 7.5K to 13.5K | |
| 22-Mar-22 11:56 AM View: | Swandal Craig A. Director | Bovie Medical Corp. (APYX) | 21-Mar-22 | Option Exercise | 17,000 | $4.98 | $84,660.00 | 100% 0 to 17.0K | |
| 22-Mar-23 4:28 PM View: | Swandal Craig A. Director | Bovie Medical Corp. (APYX) | 07-Jan-22 | Option Exercise | 7,173 | $9.42 | $67,569.70 | 14% 53.0K to 60.17K | |
| 08-Mar-21 3:09 PM View: | Waldman Lawrence Director | Bovie Medical Corp. (APYX) | 08-Mar-21 | Option Exercise | 5,563 | $2.81 | $15,632.00 | 100% 0 to 5.56K | |
| 08-Mar-21 3:08 PM View: | Geraghty Michael Director | Bovie Medical Corp. (APYX) | 05-Mar-21 | Option Exercise | 7,500 | $2.81 | $21,075.00 | 100% 0 to 7.5K | |
| 12-Feb-21 10:00 PM View: | Swandal Craig A. Director | Bovie Medical Corp. (APYX) | 07-Oct-20 | Option Exercise | 7,084 | $7.28 | $51,571.50 | 71% 9.92K to 17.0K | |
| 14-May-20 1:27 PM View: | Goodwin Charles D. II Chief Executive Officer Director | Bovie Medical Corp. (APYX) | 13-May-20 | Market Purchase | 28,250 | $3.30 | $93,196.80 | 100% 0 to 28.25K | |
| 12-Feb-21 10:00 PM View: | Swandal Craig A. Director | Bovie Medical Corp. (APYX) | 04-Mar-20 | Option Exercise | 9,916 | $7.28 | $72,188.50 | 140% 7.08K to 17.0K | 40% |
| 05-Mar-20 10:22 AM View: | Swandal Craig A. Director | Bovie Medical Corp. (APYX) | 01-Oct-19 | Exercise (in-the money or at-the-money) | 10,000 | $5.30 | $53,000.00 | 38% 26.0K to 36.0K | |
| 05-Mar-20 10:19 AM View: | Swandal Craig A. Director | Bovie Medical Corp. (APYX) | 04-Apr-19 | Exercise (in-the money or at-the-money) | 2,000 | $2.37 | $4,740.00 | 8% 24.0K to 26.0K | |
| 05-Mar-20 10:19 AM View: | Swandal Craig A. Director | Bovie Medical Corp. (APYX) | 04-Apr-19 | Exercise (out-of-the-money) | 6,000 | $5.30 | $31,800.00 | 33% 18.0K to 24.0K | |
| 05-Mar-20 10:17 AM View: | Swandal Craig A. Director | Bovie Medical Corp. (APYX) | 10-Jan-19 | Exercise (in-the money or at-the-money) | 18,000 | $3.67 | $66,100.00 | 100% 0 to 18.0K | |
| 09-Nov-18 3:03 PM View: | Makrides Andrew Director | Bovie Medical Corp. (APYX) | 08-Nov-18 | Gift | 6,000 | $6.84 | $41,040.00 | (< 1%) 611.97K to 605.97K | (19%) |
| 19-Aug-16 2:54 PM View: | McCarthy John J. III Chief CommercializationOfficer | Bovie Medical Corp. (APYX) | 17-Aug-16 | Market Purchase | 90,750 | $3.30 | $299,475.00 | 363% 25.0K to 115.75K | 146% |
| 23-Dec-15 9:10 AM View: | McCarthy John J. III Chief Commercialization Office | Bovie Medical Corp. (APYX) | 22-Dec-15 | Market Purchase | 25,000 | $1.98 | $49,427.50 | 100% 0 to 25.0K | 313% |
| 23-Dec-15 9:12 AM View: | Citronowicz Moshe Sr. V.P. of Operations | Bovie Medical Corp. (APYX) | 21-Dec-15 | Market Purchase | 20,000 | $1.84 | $36,774.00 | 5% 406.5K to 426.5K | 344% |
| 23-Dec-15 9:09 AM View: | Gershon Robert Chief Executive Officer Director | Bovie Medical Corp. (APYX) | 21-Dec-15 | Market Purchase | 10,000 | $1.82 | $18,168.00 | 50% 20.0K to 30.0K | 349% |
| 17-Aug-15 5:30 PM View: | Gershon Robert Chief Executive Officer Director | Bovie Medical Corp. (APYX) | 14-Aug-15 | Market Purchase | 20,000 | $2.39 | $47,800.00 | 100% 0 to 20.0K | 242% |
| 18-Mar-15 3:56 PM View: | Sheffield Ian Director | Bovie Medical Corp. (APYX) | 17-Mar-15 | Grant | 480,000 | $2.50 | $1,200,000.00 | 100% 0 to 480.0K | 226% |
| 23-Sep-14 12:37 PM View: | Makrides Andrew Director | Bovie Medical Corp. (APYX) | 19-Sep-14 | Option Exercise | 25,000 | $2.13 | $53,250.00 | 4% 599.21K to 624.21K | |
| 23-Sep-14 12:38 PM View: | Saron J Robert President Director | Bovie Medical Corp. (APYX) | 19-Sep-14 | Payment of Exercise | 6,121 | $4.35 | $26,626.30 | 2% 375.08K to 381.2K | 87% |
| 23-Sep-14 12:37 PM View: | Makrides Andrew Director | Bovie Medical Corp. (APYX) | 19-Sep-14 | Payment of Exercise | 12,241 | $4.35 | $53,248.30 | (2%) 624.21K to 611.97K | (87%) |
| 23-Sep-14 12:38 PM View: | Saron J Robert President Director | Bovie Medical Corp. (APYX) | 19-Sep-14 | Option Exercise | 12,500 | $2.13 | $26,625.00 | 3% 381.2K to 393.7K | |
| 04-Oct-13 8:50 AM View: | Kromer George W Director | Bovie Medical Corp. (APYX) | 01-Oct-13 | Gift | 4,000 | $2.91 | $11,640.00 | (2%) 251.51K to 247.51K | (180%) |
| 10-Dec-12 9:51 PM View: | Kromer George W Director | Bovie Medical Corp. (APYX) | 05-Dec-12 | Gift | 5,000 | $2.65 | $13,250.00 | (2%) 256.51K to 251.51K | (208%) |
| 20-Sep-12 4:11 PM View: | Kromer George W Director | Bovie Medical Corp. (APYX) | 06-Sep-12 | Gift | 5,000 | $2.66 | $13,300.00 | (2%) 261.51K to 256.51K | (206%) |
| 29-Dec-11 9:41 PM View: | Konesky Gregory Alan Director | Bovie Medical Corp. (APYX) | 23-Dec-11 | Market Sale | 750 | $2.40 | $1,800.00 | (30%) 2.5K to 1.75K | (229%) |
| 29-Aug-11 4:38 PM View: | Renaissance Us Growth & Inc... Director | Bovie Medical Corp. (APYX) | 25-Aug-11 | Market Purchase | 7,100 | $2.70 | $19,170.00 | < 1% 1.24M to 1.25M | 175% |
| 29-Aug-11 4:38 PM View: | Renaissance Us Growth & Inc... Director | Bovie Medical Corp. (APYX) | 24-Aug-11 | Market Purchase | 14,100 | $2.66 | $37,531.40 | 1% 1.23M to 1.24M | 179% |
| 29-Aug-11 4:38 PM View: | Renaissance Us Growth & Inc... Director | Bovie Medical Corp. (APYX) | 23-Aug-11 | Market Purchase | 11,600 | $2.55 | $29,580.00 | < 1% 1.22M to 1.23M | 192% |
| 16-Aug-11 11:39 AM View: | Renaissance Us Growth & Inc... 10% Owner | Bovie Medical Corp. (APYX) | 09-Aug-11 | Market Purchase | 115,000 | $2.40 | $276,350.00 | 10% 1.1M to 1.22M | 209% |
| 09-Jun-11 3:59 PM View: | Kromer George W Director | Bovie Medical Corp. (APYX) | 08-Jun-11 | Market Sale | 5,000 | $2.87 | $14,350.00 | (2%) 266.51K to 261.51K | (159%) |
| 24-May-11 10:49 AM View: | Konesky Gregory Alan Director | Bovie Medical Corp. (APYX) | 20-May-11 | Market Sale | 800 | $2.99 | $2,392.00 | (24%) 3.3K to 2.5K | (148%) |
| 08-Mar-11 3:06 PM View: | Renaissance Us Growth & Inc... 10% Owner | Bovie Medical Corp. (APYX) | 07-Mar-11 | Market Purchase | 150,000 | $2.57 | $385,500.00 | (12%) 1.25M to 1.1M | (189%) |
| 06-Dec-10 9:55 PM View: | Pardoll Peter Director | Bovie Medical Corp. (APYX) | 03-Dec-10 | Market Sale | 6,078 | $3.08 | $18,720.20 | (9%) 69.23K to 63.15K | (146%) |
| 06-Dec-10 9:55 PM View: | Pardoll Peter Director | Bovie Medical Corp. (APYX) | 02-Dec-10 | Market Sale | 14,778 | $3.10 | $45,811.80 | (18%) 84.01K to 69.23K | (144%) |
| 06-Dec-10 9:55 PM View: | Pardoll Peter Director | Bovie Medical Corp. (APYX) | 02-Dec-10 | Market Sale | 2,700 | $3.09 | $8,343.00 | (3%) 86.71K to 84.01K | (145%) |
